Thomas Lepitre

Thomas Lepitre is a seasoned professional in the pharmaceutical industry, currently serving as the Drug Discovery Program Lead at Qubit Pharmaceuticals since October 2024. Prior to this role, Thomas held positions at Paraza Pharma Inc. from April 2019 to October 2024, where responsibilities included both Senior Scientist and Research Scientist roles. Academic experience includes a Postdoctoral Researcher position at Harvard University from November 2017 to April 2019 and a PhD Researcher role at LABORATOIRE URCOM from October 2014 to October 2017. Early career experience involves research assistant roles at Servier and CSIRO in 2014 and 2013, respectively. Thomas holds a Diplôme d'ingénieur in organic/medicinal chemistry from Chimie ParisTech - PSL, obtained between 2011 and 2014.